D&D Charity Adventure: The Message Digital Download

$5.00 USD

In this very special charity campaign the D&D is for Nerds crew take on the roll of small defenceless critters with a very important message to deliver and very little time to do it in.

Small and alone, in a hostile world of dangers, a few brave heroes must find a way to overcome villains far greater than themselves while keeping their own hope alive. Questioning themselves and the monumental task before them, will they succeed where stronger creatures fail? Can their strength, bravery, wisdom and faith exceed their small stature? And can they even succeed in time before their limited magic runs out? What chance could such small woodland creatures stand against these monumental odds? But, when destiny calls, they will deliver.

All proceeds from this adventure will go to support PSC Support UK – a charity dedicated to helping people affected by Primary Sclerosing Cholangitis (a rare disease that our friend Mark has). You can find out more about the charity by visiting its website.



PSC is short for Primary Sclerosing Cholangitis, a chronic liver disease whereby the bile ducts, which are the passages that carry bile from the liver to the intestines, become narrowed from inflammation and fibrosis. Over time, the scar tissue builds up and can block parts of the bile ducts completely. The blockages can occur in any part of the biliary tree: inside the liver itself (intrahepatic) or outside the liver (extrahepatic).

The narrowed or blocked bile ducts interrupt the flow of bile out of the liver, causing a variety of symptoms; ultimately in some patients leading to biliary cirrhosis, portal hypertension, and liver failure. Common symptoms can include tiredness, generalised aching, pruritus (itching), pain in the upper right side of the abdomen, jaundice, chills and fevers. Many people with PSC are asymptomatic at the point of diagnosis, that is, don’t even show any outward symptoms to indicate they are living with a chronic illness. Not only that, but the progression of the disease is highly variable between patients: the speed of progression of PSC, severity and the number of symptoms cannot be predicted for the individual patient.